Chris Nave
Investing Profile
Brandon Capital Partners thesis
Advancell Clinical-stage radiopharmaceutical company developing targeted alpha therapies to treat a broad range of cancers. Aravax Pty Ltd Developing peptide-based immunotherapies for food allergy treatment AstronauTx Cutting-edge biotech company founded to target neurodegenerative diseases by improving disrupted physiological processes leading to dementia. Axelia Oncology Biopharmaceutical company aiming to transform the treatment of checkpoint insensitive cancers through the activation of TLR2/6 engagement of the innate immune response. Azura Ophthalmics Developing first-in-class ophthalmic
Sector and stage focus
- Seed: Medical Devices, Pharmaceuticals, Education, BioTech, Therapeutics, Health & Hospital Services
- Pre-seed: Medical Devices, Pharmaceuticals, Education, BioTech, Health & Hospital Services, Therapeutics
Recent investments by Chris Nave
Chris Nave has 1 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Azura Ophthalmics | Series B | Oct 2017 | $16M |
Frequent co-investors
Chris Nave has co-invested with: Heather Preston.
Is Chris Nave a fit for your round?
Upload your pitch deck and see whether Chris Nave appears in your top 20 matches.
Find investors for your deck